Submit a manuscript Register Sign up for article alerts Contact us Support

Articles

Volume 7 (2009) - May 2009

next >
up
< previous

Research   Open Access

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

Hye Chung, Sang-Guk Lee, Heejung Kim, Duck Hong, Jae Chung, David Stroncek, Jong-Baeck Lim Journal of Translational Medicine 2009, 7:38 (28 May 2009)

Abstract | Full text | PDF | PubMed

Research   Open Access

Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study

Chiung-Ling Liao, Ming-Yung Lee, Yeu-Sheng Tyan, Lai-Fong Kok, Tina S Wu, Chiew-Loon Koo, Po-Hui Wang, Kuan-Chong Chao, Chih-Ping Han Journal of Translational Medicine 2009, 7:37 (28 May 2009)

Abstract | Full text | PDF | PubMed

Research   Open Access

An intron 9 containing splice variant of PAX2

Antonia Busse, Anika Rietz, Stefan Schwartz, Eckhard Thiel, Ulrich Keilholz Journal of Translational Medicine 2009, 7:36 (25 May 2009)

Abstract | Full text | PDF | PubMed

Research   Open Access

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

Erika von Euw, Thinle Chodon, Narsis Attar, Jason Jalil, Richard C Koya, Begonya Comin-Anduix, Antoni Ribas Journal of Translational Medicine 2009, 7:35 (20 May 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research   Open Access Highly Accessed

Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells

Davy CW Lee, Cindy LH Yang, Stanley CC Chik, James CB Li, Jian-hui Rong, Godfrey CF Chan, Allan SY Lau Journal of Translational Medicine 2009, 7:34 (14 May 2009)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Beneficial effects attributed to ginseng could in part be explained as a ginsenoside induced anti-inflammatory response mediated by tumour necrosis factor-alpha suppression.

Research   Open Access Highly Accessed

Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life

Hemant Sarin, Ariel S Kanevsky, Steve H Fung, John A Butman, Robert W Cox, Daniel Glen, Richard Reynolds, Sungyoung Auh Journal of Translational Medicine 2009, 7:33 (13 May 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Editorial   Open Access

AAAS joins the Translational Medicine family

Christian Brander, Francesco M Marincola Journal of Translational Medicine 2009, 7:32 (7 May 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central